A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference81 articles.
1. TCM: made in China;F Cheung;Nature,2011
2. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science;W-Y Jiang;Trends in pharmacological sciences,2005
3. Multi-target therapeutics: when the whole is greater than the sum of the parts;GR Zimmermann;Drug Discov Today,2007
4. The human disease network;K-I Goh;Proceedings of the National Academy of Sciences,2007
5. Chronic diseases: the emerging pandemic;A Terzic;Clin Transl Sci,2011
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver;Phytomedicine;2024-01
2. Network pharmacology and molecular docking study-based approach to explore mechanism of benzimidazole-based anthelmintics for the treatment of lung cancer;Journal of Biomolecular Structure and Dynamics;2023-09-23
3. Development of Novel Herbal Compound Formulations Targeting Neuroinflammation: Network Pharmacology, Molecular Docking, and Experimental Verification;Evidence-Based Complementary and Alternative Medicine;2023-05-24
4. Study on Anti-inflammatory Mechanism of Blueberry based on Network Pharmacology and Molecular Docking Technology;Combinatorial Chemistry & High Throughput Screening;2023-02
5. Physiological Characteristics and Proteome of Dalbergia odorifera in Loam and Gravel Substrates;Horticulturae;2022-12-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3